Laman UtamaNATCOPHARM • NSE
add
Natco Pharma Ltd.
Tutup sebelumnya
₹1,382.90
Julat hari
₹1,385.85 - ₹1,423.00
Julat tahun
₹724.20 - ₹1,639.00
Permodalan pasaran
253.44B INR
Bilangan Purata
947.94K
Nisbah P/E
15.49
Hasil dividen
0.39%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 13.63B | 19.47% |
Perbelanjaan pengendalian | 4.22B | 3.11% |
Pendapatan bersih | 6.68B | 59.05% |
Margin untung bersih | 49.06 | 33.13% |
Pendapatan bagi setiap syer | 37.32 | 60.45% |
EBITDA | 8.07B | 40.06% |
Kadar cukai berkesan | 16.81% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 18.49B | 59.13% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 58.53B | — |
Syer tertunggak | 179.13J | — |
Harga kepada buku | 4.23 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 30.55% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 6.68B | 59.05% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Diasaskan
1981
Ibu pejabat
Tapak web
Pekerja
4,016
